【24h】

Evaluation of a scoring system for assessing prognosis in pediatric acute liver failure.

机译:评估儿科急性肝衰竭预后评分系统的评价。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND & AIMS: Pediatric acute liver failure (PALF) results in death or need for liver transplantation (LT) in up to 50% of patients. A scoring system for predicting death or LT (Liver Injury Units [LIU] score) in PALF was previously derived by our group, and used peak values during hospital admission of total bilirubin, prothrombin time/international normalized ratio, and ammonia as significant predictors of outcome. The aims of this study were to test the predictive value of the LIU score in a subsequent validation set of patients and to derive a hospital admission LIU (aLIU) score predictive of outcome. METHODS: Data were obtained from 53 children admitted with PALF from 2002 to 2006. Outcome was defined at 16 weeks as alive without LT, death, or LT. RESULTS: Survival without LT at 16 weeks for each LIU score quartile was 92%, 44%, 60%, and 12%, respectively (P < .001). The receiver operating characteristic C index for predicting death or LT by 4 weeks was 86.3. An admission LIU score was derived using admission total bilirubin and prothrombin time/international normalized ratio. Survival without LT at 16 weeks for each quartile using the aLIU score was 85%, 77%, 69%, and 31% (P = .001). The receiver operating characteristic C index for predicting death or LT by 4 weeks was 83.7. CONCLUSIONS: The original LIU score is a valid predictor of outcome in PALF. The aLIU score is promising and needs to be validated in subsequent patients.
机译:背景和目的:小儿急性肝功能衰竭(PALF)导致死亡或需要肝移植(LT),高达50%的患者。用于预测死亡或肝脏(肝损伤单位[Liu]评分)的评分系统以前由我们的小组衍生,并在入院期间使用峰值峰值,凝血酶原时间/国际规范化比例和氨作为重要预测因子结果。本研究的目的是测试随后的验证组中刘分的预测价值,并导致刘(Aliu)评分预测结果。方法:从2002年至2006年患有PALF的53名儿童获得数据。结果是在没有LT,死亡,或LT的情况下在15周内定义的结果。结果:每次刘评分四周的16周内生存率分别为92%,44%,60%和12%(P <.001)。接收器操作特征C指数用于预测死亡或4周的死亡率为86.3。使用胆红素和凝血酶原时间/国际归一化比率来衍生入院刘分。使用Aliu评分的每种四分位数的15周内生存率为85%,77%,69%和31%(P = .001)。接收器操作特征C指数用于预测死亡或4周的死亡率为83.7。结论:原来的刘分是Palf中的有效预测因子。 Aliu评分是有前途的,需要在随后的患者中验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号